Eidelman Virant Capital Corcept Therapeutics Inc Transaction History

Eidelman Virant Capital

  • $136 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 18, 2019
SELL
$11.29 - $17.19 $112,899 - $171,900
-10,000 Closed
0 $0
Q2 2018

Jul 24, 2018
SELL
$15.3 - $19.69 $459,000 - $590,700
-30,000 Reduced 75.0%
10,000 $157,000
Q3 2017

Oct 20, 2017
BUY
$12.3 - $19.3 $492,000 - $772,000
40,000
40,000 $722,000

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.05B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Eidelman Virant Capital Portfolio

Follow Eidelman Virant Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

News

Stay updated on Eidelman Virant Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email